Feasibility of Reducing Cardiovascular Disease Risk Factors in Hispanics Through a Family-Based Community Intervention

April 1, 2024 updated by: Gary J. Luckasen, MD, Poudre Valley Health System
The purpose of this study is to evaluate the feasibility of a 6-month family-based community intervention to mitigate cardiovascular disease risk factors in Hispanic families in northern Colorado as measured through biometric screenings, body composition, physical activity, and health knowledge.

Study Overview

Status

Recruiting

Detailed Description

The current project aims to leverage the UCHealth Healthy Hearts Family Program to provide a free, non-insurance-based 1-year cardiovascular disease (CVD) prevention and wellness program to Hispanic Colorado families. This program includes an interactive educational class series, baseline and quarterly biometric screenings, and optional consultations with an Exercise Physiologist and a Dietitian. This program takes a novel approach to preventative care by incorporating the family unit with the intention of having the child be the agent of change. The long-term goals of this project are to significantly improve CVD risk factors among participating families and to disseminate study findings to inform developing and current outreach programs to offer effective CVD prevention programs for Hispanic citizens. This work may ultimately lead to more Hispanics being served through new or existing programs, therefore expanding important preventative community health interventions into this underserved population.

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Colorado
      • Loveland, Colorado, United States, 80528
        • Recruiting
        • Medical Center of the Rockies
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • At least one member of the family unit self-identifies as Hispanic
  • At least 13 years of age

Exclusion Criteria:

  • Unwilling to wear Fitbit devices daily for 6 months except when charging and sleeping
  • Cannot read or understand either English or Spanish
  • Cannot return to screening location to perform the minimum of the baseline, 3-month and 6-month follow-up screenings
  • Children or adolescents will be excluded from this project without a minimum of one accompanying parent or guardian

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Healthy Hearts Family Program
Participants will be enrolled in the standard Healthy Hearts Family Program 6-month family-based cardiovascular disease prevention program.
Participants will participate in a baseline health and knowledge screening, followed by a 6-week once-weekly class series, and 3- and 6-month follow-up health and knowledge screenings.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Efficacy of program through changes in physical health - Daily Steps
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Physical activity metrics (daily average steps per month) measured by Fitbit devices
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Physical Activity
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Physical activity metrics (daily minutes of light, moderate and vigorous activity per month) measured by Fitbit devices
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Blood Pressure
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Biometric variables (blood pressure in mmHg)
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Lab Value -Lipid Profile
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Biometric variables - lab values (lipid profile in mg/dL) measured through finger stick blood sampling
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Lab Value - Triglycerides
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Biometric variables - lab values ( triglycerides in mg/dL) measured through finger stick blood sampling
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Lab Value - Blood Glucose
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Biometric variables - lab values (blood glucose all in mg/dL) measured through finger stick blood sampling
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Waist Circumference
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Body composition (waist circumference in inches)
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Body Composition - Muscle Mass
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Body composition (muscle mass in pounds) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device.
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Body Composition - Fat Mass
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Body composition (fat-free mass in pounds) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device.
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Body Fat Percentage
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Body composition (body fat percentage) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device.
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in physical health - Visceral Fat Rating
Time Frame: Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Body composition (Tanita visceral fat rating) measured with a Tanita MC980Uplus multi-frequency bio-electrical impedance analysis device.
Baseline, 3-month follow up and 6-month follow up data will be evaluated and compared
Efficacy of program through changes in health knowledge
Time Frame: Baseline, post-6 week class series, 3- and 6-month follow-up appointments.
Health knowledge gained and retained will be evaluated and compared at baseline, post-6 week class series, 3- and 6-month follow-ups utilizing previously developed and utilized Healthy Hearts knowledge survey. This outcome will be measured by correct responses on the Healthy Hearts knowledge survey.
Baseline, post-6 week class series, 3- and 6-month follow-up appointments.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to program and utilization of additional resources - Program attendance - Percentage of Scheduled Visits Attended
Time Frame: These variables will be measured and assessed throughout the full 6 month program.
Attendance for screenings, classes and other consultations across baseline and follow-up visits. Attendance will be measured as the percentage of scheduled visits (including the 6 week class series and the 3- and 6-month follow-up visits) completed.
These variables will be measured and assessed throughout the full 6 month program.
Adherence to program and utilization of additional resources - Fitbit Utilization
Time Frame: These variables will be measured and assessed throughout the full 6 month program.
Compliance to Fitbit utilization as measured by days worn throughout the 6 month program. The NHANES compliance to wear time of > 10 hours worn per day will be utilized.
These variables will be measured and assessed throughout the full 6 month program.
Adherence to program and utilization of additional resources - Resource Utilization
Time Frame: These variables will be measured and assessed throughout the full 6 month program.
Use of Exercise Physiologist and Dietician resources provided will be quantified and reported. This outcome will be reported as the number of consultation appointments requested and utilized throughout the program.
These variables will be measured and assessed throughout the full 6 month program.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Victoria Bandera, MS, University of Colorado Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 22, 2022

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

February 25, 2022

First Submitted That Met QC Criteria

April 4, 2022

First Posted (Actual)

April 12, 2022

Study Record Updates

Last Update Posted (Actual)

April 3, 2024

Last Update Submitted That Met QC Criteria

April 1, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Clinical Trials on Healthy Hearts Family Program

3
Subscribe